Crealta Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 31
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4
  • Investments
  • 1

Crealta Pharmaceuticals General Information

Description

Manufacturer of therapeutics products. The company provides KRYSTEXXA and MIGERGOT medicines. It also offers medicine for the treatment of high uric acid and medicine for migraines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare
Therapeutic Devices
Primary Office
  • 500 West Silver Spring Drive
  • Suite K-200
  • Glendale, WI 53217
  • United States
+1 (847) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crealta Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crealta Pharmaceuticals‘s full profile, request access.

Request a free trial

Crealta Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crealta Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crealta Pharmaceuticals‘s full profile, request access.

Request a free trial

Crealta Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 13-Jan-2014 0000000000 00000 Pharmaceuticals
To view Crealta Pharmaceuticals’s complete investments history, request access »